264 related articles for article (PubMed ID: 11477074)
21. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells.
Marx N; Schönbeck U; Lazar MA; Libby P; Plutzky J
Circ Res; 1998 Nov; 83(11):1097-103. PubMed ID: 9831704
[TBL] [Abstract][Full Text] [Related]
22. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
[TBL] [Abstract][Full Text] [Related]
23. Synergistic effect of peroxisome proliferator activated receptor-gamma and liver X receptor-alpha in the regulation of inflammation in macrophages.
Piraino G; Cook JA; O'Connor M; Hake PW; Burroughs TJ; Teti D; Zingarelli B
Shock; 2006 Aug; 26(2):146-53. PubMed ID: 16878022
[TBL] [Abstract][Full Text] [Related]
24. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
[TBL] [Abstract][Full Text] [Related]
25. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
[TBL] [Abstract][Full Text] [Related]
26. Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells.
Siavash H; Nikitakis NG; Sauk JJ
Cancer Lett; 2004 Jul; 211(1):97-103. PubMed ID: 15194221
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1.
Wang C; Fu M; D'Amico M; Albanese C; Zhou JN; Brownlee M; Lisanti MP; Chatterjee VK; Lazar MA; Pestell RG
Mol Cell Biol; 2001 May; 21(9):3057-70. PubMed ID: 11287611
[TBL] [Abstract][Full Text] [Related]
28. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.
Boyault S; Simonin MA; Bianchi A; Compe E; Liagre B; Mainard D; Bécuwe P; Dauça M; Netter P; Terlain B; Bordji K
FEBS Lett; 2001 Jul; 501(1):24-30. PubMed ID: 11457450
[TBL] [Abstract][Full Text] [Related]
29. Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2.
Bishop-Bailey D; Hla T
J Biol Chem; 1999 Jun; 274(24):17042-8. PubMed ID: 10358055
[TBL] [Abstract][Full Text] [Related]
30. 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene.
Sinha D; Addya S; Murer E; Boden G
Metabolism; 1999 Jun; 48(6):786-91. PubMed ID: 10381155
[TBL] [Abstract][Full Text] [Related]
31. Peroxisome proliferator-activated receptor-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J2, reduces neutrophil migration via a nitric oxide pathway.
Napimoga MH; Vieira SM; Dal-Secco D; Freitas A; Souto FO; Mestriner FL; Alves-Filho JC; Grespan R; Kawai T; Ferreira SH; Cunha FQ
J Immunol; 2008 Jan; 180(1):609-17. PubMed ID: 18097063
[TBL] [Abstract][Full Text] [Related]
32. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.
Cippitelli M; Fionda C; Di Bona D; Lupo A; Piccoli M; Frati L; Santoni A
J Immunol; 2003 May; 170(9):4578-92. PubMed ID: 12707336
[TBL] [Abstract][Full Text] [Related]
33. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
Wayman NS; Hattori Y; McDonald MC; Mota-Filipe H; Cuzzocrea S; Pisano B; Chatterjee PK; Thiemermann C
FASEB J; 2002 Jul; 16(9):1027-40. PubMed ID: 12087064
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: involvement of physical association between PPAR-gamma and the nuclear factor of activated T cells transcription factor.
Chung SW; Kang BY; Kim TS
Mol Pharmacol; 2003 Nov; 64(5):1169-79. PubMed ID: 14573767
[TBL] [Abstract][Full Text] [Related]
35. Identification of 15d-PGJ2 as an antagonist of farnesoid X receptor: molecular modeling with biological evaluation.
Xu X; Lu Y; Chen L; Chen J; Luo X; Shen X
Steroids; 2013 Sep; 78(9):813-22. PubMed ID: 23707573
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.
Shimada T; Kojima K; Yoshiura K; Hiraishi H; Terano A
Gut; 2002 May; 50(5):658-64. PubMed ID: 11950812
[TBL] [Abstract][Full Text] [Related]
37. 15-Deoxy-Δ12,14-prostaglandin J2 induces PPARγ- and p53-independent apoptosis in rabbit synovial cells.
Sakaba Y; Awata H; Morisugi T; Kawakami T; Sakudo A; Tanaka Y
Prostaglandins Other Lipid Mediat; 2014 Jun; 109-111():1-13. PubMed ID: 24680891
[TBL] [Abstract][Full Text] [Related]
38. 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) mediates repression of TNF-alpha by decreasing levels of acetylated histone H3 and H4 at its promoter.
Engdahl R; Monroy MA; Daly JM
Biochem Biophys Res Commun; 2007 Jul; 359(1):88-93. PubMed ID: 17532302
[TBL] [Abstract][Full Text] [Related]
39. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2.
Butler R; Mitchell SH; Tindall DJ; Young CY
Cell Growth Differ; 2000 Jan; 11(1):49-61. PubMed ID: 10672903
[TBL] [Abstract][Full Text] [Related]
40. Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression.
Hounoki H; Sugiyama E; Mohamed SG; Shinoda K; Taki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Miyahara T
Bone; 2008 Apr; 42(4):765-74. PubMed ID: 18242157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
